NWC21 Keynote Presentation - Mark Palmer

About the Presenter

Mark Palmer, MD, PhD is a Distinguished Scientist in the Core Technologies group within Corporate Strategic Scientific Operations at Medtronic, plc. In his current role, Mark leads an internal team of advanced modeling and simulation consultants servicing the global enterprise, manages external collaborations, and leads the strategy and platform technologies for realistic human simulation. Mark serves as a member of the Enterprise AI Working Group and leads the Enterprise Modeling and Simulation Working Group where he regularly reports to the R&D Council, Clinical Research Council, Executive Committee and the Board of Directors on the long-range R&T Strategy for Modeling & Simulation. Mark’s expertise includes fully coupled multi-scale finite element methods, large deformation tissue mechanics and modeling, and clinical image-based modeling techniques. In 2020, Mark was named a Medtronic Technical Fellow for his outstanding contributions to the company’s technical excellence.

Prior to being recruited by Medtronic in 2014, Mark received his BS in Mechanical & Aerospace Engineering from Princeton University. His graduate work at the University of Michigan included the dual Masters program (Biomedical and Mechanical Engineering) and the NIH funded Medical Scientist Training Program (MSTP) with a Ph.D. in Mechanical Engineering. Mark spent three years as an entrepreneur before returning to the University of Michigan as a faculty member with appointments in Biomedical Engineering and Kinesiology. Mark serves on the NAFEMS Business Impact Working Group and Industry Advisory Boards for ASME and CompBioMed. He also represents Medtronic on the ASME Verification & Validation 40 Standard for Modeling and Simulation and the ASME Verification and Validation 70 Standard for AI and Machine Learning. Mark is passionate about advancing human simulation, virtual patient technologies, and digital evidence standards for the medical device industry.